Abstract
Background
The relationship between human milk oligosaccharides (HMOs) and infant growth and adiposity is not fully understood and comprehensive studies are missing from the current literature.
Methods
We screened and recruited 370 healthy, pregnant women and their infants from seven European countries. Breastmilk samples were collected using standardized procedures at six time points over 4 months, as were infant parameters. Correlations and associations between HMO area under the curve, anthropometric data, and fat mass at 4 months were tested.
Results
Lacto-N-neotetraose had a negative correlation with the change in length (rs = −0.18, P = 0.02). Sialyllacto-N-tetraose c (LSTc) had a positive correlation with weight for length (rs = 0.19, P = 0.015). Infants at the 25th upper percentile were fed milk higher in 3′-sialyllactose and LSTc (P = 0.017 and P = 0.006, respectively) compared to the lower 25th percentile of the weight-for-length z-score gain over 4 months of lactation. No significant associations between growth and body composition and Lewis or secretor-dependent HMOs like 2′-fucosyllactose were identified.
Conclusions
Changes in the HMO composition of breastmilk during the first 4 months appear to have little influence on infant growth and body composition in this cohort of healthy mothers and infants.
Impact
-
Modest associations exist between individual HMO and infant growth outcomes at least in healthy growing populations.
-
Our study provides a comprehensive investigation of associations between all major HMO and infant growth and adiposity including several time points. Certain groups of HMOs, like the sialylated, may be associated with adiposity during the first months of lactation.
-
HMO may modulate the risk of future metabolic disease. Future population studies need to address the role of specific groups of HMOs in the context of health and disease to understand the long-term impact.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
137,91 €
only 10,61 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.






References
Ballard, O. & Morrow, A. L. Human milk composition: nutrients and bioactive factors. Pediatr. Clin. N. Am. 60, 49–74 (2013).
Andreas, N. J., Kampmann, B., Mehring & Le-Doare, K. Human breast milk: a review on its composition and bioactivity. Early Hum. Dev. 91, 629–635 (2015).
Kunz, C., Rodriguez-Palmero, M., Koletzko, B. & Jensen, R. Nutritional and biochemical properties of human milk, Part I: general aspects, proteins, and carbohydrates. Clin. Perinatol. 26, 307–333 (1999).
Coppa, G. V. et al. Changes in carbohydrate composition in human milk over 4 months of lactation. Pediatrics 91, 637–641 (1993).
Bode, L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 22, 1147–1162 (2012).
Kunz, C., Rudloff, S., Baier, W., Klein, N. & Strobel, S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu. Rev. Nutr. 20, 699–722 (2000).
Kunz, C. et al. Influence of gestational age, secretor, and lewis blood group status on the oligosaccharide content of human milk. J. Pediatr. Gastroenterol. Nutr. 64, 789–798 (2017).
Sprenger, N., Binia, A. & Austin, S. Human milk oligosaccharides: factors affecting their composition and their physiological significance. Nestle Nutr. Inst. Workshop Ser. 90, 43–56 (2019).
Van Niekerk, E. et al. Human milk oligosaccharides differ between HIV-infected and HIV-uninfected mothers and are related to necrotizing enterocolitis incidence in their preterm very-low-birth-weight infants. J. Nutr. 144, 1227–1233 (2014).
Smilowitz, J. T., Lebrilla, C. B., Mills, D. A., German, J. B. & Freeman, S. L. Breast milk oligosaccharides: structure-function relationships in the neonate. Annu. Rev. Nutr. 34, 143–169 (2014).
Thurl, S., Henker, J., Siegel, M., Tovar, K. & Sawatzki, G. Detection of four human milk groups with respect to Lewis blood group dependent oligosaccharides. Glycoconj. J. 14, 795–799 (1997).
Stahl, B. et al. Detection of four human milk groups with respect to Lewis-blood-group-dependent oligosaccharides by serologic and chromatographic analysis. Adv. Exp. Med. Biol. 501, 299–306 (2001).
Kumazaki, T. & Yoshida, A. Biochemical evidence that secretor gene, Se, is a structural gene encoding a specific fucosyltransferase. Proc. Natl Acad. Sci. USA 81, 4193–4197 (1984).
Samuel, T. M. et al. Impact of maternal characteristics on human milk oligosaccharide composition over the first 4 months of lactation in a cohort of healthy European mothers. Sci. Rep. 9, 11767 (2019).
Rudloff, S. & Kunz, C. Milk oligosaccharides and metabolism in infants. Adv. Nutr. 3, 398s–405s (2012).
Goehring, K. C., Kennedy, A. D., Prieto, P. A. & Buck, R. H. Direct evidence for the presence of human milk oligosaccharides in the circulation of breastfed infants. PLoS ONE 9, e101692 (2014).
Vandenplas, Y. et al. Human milk oligosaccharides: 2’-fucosyllactose (2’-FL) and lacto-N-neotetraose (LNnT) in infant formula. Nutrients 10, 1161 (2018).
Alderete, T. L. et al. Associations between human milk oligosaccharides and infant body composition in the first 6 mo of life. Am. J. Clin. Nutr. 102, 1381–1388 (2015).
Larsson, M. W. et al. Human milk oligosaccharide composition is associated with excessive weight gain during exclusive breastfeeding-an explorative study. Front. Pediatr. 7, 297 (2019).
Davis, J. C. et al. Growth and morbidity of Gambian infants are influenced by maternal milk oligosaccharides and infant gut microbiota. Sci. Rep. 7, 40466 (2017).
Charbonneau, M. R. et al. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell 164, 859–871 (2016).
Cowardin, C. A. et al. Mechanisms by which sialylated milk oligosaccharides impact bone biology in a gnotobiotic mouse model of infant undernutrition. Proc. Natl Acad. Sci. USA 116, 11988–11996 (2019).
Sprenger, N., Lee, L. Y., De Castro, C. A., Steenhout, P. & Thakkar, S. K. Longitudinal change of selected human milk oligosaccharides and association to infants’ growth, an observatory, single center, longitudinal cohort study. PLoS ONE 12, e0171814 (2017).
Phipps, K. R. et al. Safety evaluation of a mixture of the human-identical milk oligosaccharides 2’-fucosyllactose and difucosyllactose. Food Chem. Toxicol. 120, 552–565 (2018).
Lee, S. et al. 2’-Fucosyllactose supplementation improves gut-brain signaling and diet-induced obese phenotype and changes the gut microbiota in high fat-fed mice. Nutrients 12, 1003 (2020).
Fields, D. A., Higgins, P. B. & Radley, D. Air-displacement plethysmography: here to stay. Curr. Opin. Clin. Nutr. Metab. Care 8, 624–629 (2005).
Ellis, K. J. et al. Body-composition assessment in infancy: air-displacement plethysmography compared with a reference 4-compartment model. Am. J. Clin. Nutr. 85, 90–95 (2007).
Urlando, A., Dempster, P. & Aitkens, S. A new air displacement plethysmograph for the measurement of body composition in infants. Pediatr. Res. 53, 486–492 (2003).
Austin, S. & Benet, T. Quantitative determination of non-lactose milk oligosaccharides. Anal. Chim. Acta 1010, 86–96 (2018).
van Leeuwen, S. S. et al. Rapid milk group classification by 1H NMR analysis of Le and H epitopes in human milk oligosaccharide donor samples. Glycobiology 24, 728–739 (2014).
WHO MGRS Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl. 450, 76–85 (2006).
Victora, C. G. et al. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 371, 340–357 (2008).
Martorell, R. & Zongrone, A. Intergenerational influences on child growth and undernutrition. Paediatr. Perinat. Epidemiol. 26(Suppl. 1), 302–314 (2012).
Subramanian, S. et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 510, 417–421 (2014).
Smith, M. I. et al. Gut microbiomes of Malawian twin pairs discordant for Kwashiorkor. Science 339, 548–554 (2013).
Mosca, F. & Gianni, M. L. Human milk: composition and health benefits. Pediatr. Med. Chir. 39, 155 (2017).
Eriksen, K. G., Christensen, S. H., Lind, M. V. & Michaelsen, K. F. Human milk composition and infant growth. Curr. Opin. Clin. Nutr. Metab. Care 21, 200–206 (2018).
Coppa, G. V. et al. Oligosaccharides in 4 different milk groups, Bifidobacteria, and Ruminococcus obeum. J. Pediatr. Gastroenterol. Nutr. 53, 80 (2011).
Austin, S. et al. Temporal change of the content of 10 oligosaccharides in the milk of Chinese urban mothers. Nutrients 8, 346 (2016).
Lefebvre, G. et al. Time of lactation and maternal fucosyltransferase genetic polymorphisms determine the variability in human milk oligosaccharides. Front. Nutr. 29, 574459 (2020).
De Leoz, M. L. et al. Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. J. Proteome Res. 11, 4662–4672 (2012).
Austin, S. et al. Human milk oligosaccharides in the milk of mothers delivering term versus preterm infants. Nutrients 11, 1282 (2019).
Spevacek, A. R. et al. Infant maturity at birth reveals minor differences in the maternal milk metabolome in the first month of lactation. J. Nutr. 145, 1698–1708 (2015).
Nakhla, T., Fu, D., Zopf, D., Brodsky, N. L. & Hurt, H. Neutral oligosaccharide content of preterm human milk. Br. J. Nutr. 82, 361–367 (1999).
Cheng, L. et al. More than sugar in the milk: human milk oligosaccharides as essential bioactive molecules in breast milk and current insight in beneficial effects. Crit. Rev. Food Sci. Nutr. 24, 1–17 (2020).
Berger, B. et al. Linking human milk oligosaccharides, infant fecal community types, and later risk to require antibiotics. mBio 11, 03196–19 (2020).
Backhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 690–703 (2015).
Korpela, K. et al. Fucosylated oligosaccharides in mother’s milk alleviate the effects of caesarean birth on infant gut microbiota. Sci. Rep. 8, 13757 (2018).
Matsuki, T. et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat. Commun. 24, 11939 (2016).
Macfarlane, G. T. & Macfarlane, S. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J. Clin. Gastroenterol. 45(Suppl.), 120–127 (2011).
Rasmussen, S. H. et al. Antibiotic exposure in early life and childhood overweight and obesity: a systematic review and meta-analysis. Diabetes Obes. Metab. 20, 1508–1514 (2018).
Victora, C. G. et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 30, 475–490 (2016).
Larsson, M. W. et al. Excessive weight gain followed by catch-down in exclusively breastfed infants: an exploratory study. Nutrients 10, 1290 (2018).
Larsson, M. W., Larnkjaer, A., Christensen, S. H., Molgaard, C. & Michaelsen, K. F. Very high weight gain during exclusive breastfeeding followed by slowdown during complementary feeding: two case reports. J. Hum. Lact. 35, 44–48 (2019).
Alexander, D. D. et al. Growth of infants consuming whey-predominant term infant formulas with a protein content of 1.8 g/100 kcal: a multicenter pooled analysis of individual participant data. Am. J. Clin. Nutr. 104, 1083–1092 (2016).
Lagström, H. et al. Associations between human milk oligosaccharides and growth in infancy and early childhood Am. J. Clin. Nutr. 769–778 (2020).
Storm, H. M. et al. 2’-Fucosyllactose is well tolerated in a 100% whey, partially hydrolyzed infant formula with bifidobacterium lactis: a randomized controlled trial. Glob. Pediatr. Health 6, https://doi.org/10.1177/2333794X19833995 (2019).
Puccio, G. et al. Effects of infant formula with human milk oligosaccharides on growth and morbidity: a randomized multicenter trial. J. Pediatr. Gastroenterol. Nutr. 64, 624–631 (2017).
Marriage, B. J., Buck, R. H., Goehring, K. C., Oliver, J. S. & Williams, J. A. Infants fed a lower calorie formula with 2’FL show growth and 2’FL uptake like breast-fed infants. J. Pediatr. Gastroenterol. Nutr. 61, 649–658 (2015).
Kajzer, J., Oliver, J. & Marriage, B. Gastrointestinal tolerance of formula supplemented with oligosaccharides. FASEB J. 30(Suppl.), 671.4-.4 (2016).
Acknowledgements
This study was funded by Nestlé Research, Société des Produits Nestlé, Switzerland.
Author information
Affiliations
Contributions
A.B., L.L., C.C., S.A., E.C.-G., M.A., I.A.-J., A.B.P., M.J.C., M.G.S., G.M., C.M.-C., T.S., S.-M.S., M.V., T.R., C.B., J.-C.P., and M.D., had substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data. A.B., N.S., R.A., M.V., M.A., M.J.C., C.M.C., and M.D. drafted the article and/or revised it critically for important intellectual content; and all authors had a final approval of the version to be published.
Corresponding author
Ethics declarations
Competing interests
A.B., L.L., C.C., S.A., E.C.-G., and N.S. are or were (ECG) employees of Société des Produits Nestlé during the study. R.A.’s work on this manuscript was funded by Société des Produits Nestlé. All other authors M.A., I.A.-J., A.B.P., M.J.C., M.G.S., G.M., C.M.-C., T.S., S.-M.S., M.V., T.R., C.B., J.-C.P., and M.D. received funding from Société des Produits Nestlé S.A. to conduct the study.
Statement of consent
The participants provided a written informed consent form to participate in the study after receiving explanations and having read and understood the purpose and the objectives of the study in their respective local languages. The study was registered at www.clinicaltrials.gov with the identifier NCT01894893.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Binia, A., Lavalle, L., Chen, C. et al. Human milk oligosaccharides, infant growth, and adiposity over the first 4 months of lactation. Pediatr Res 90, 684–693 (2021). https://doi.org/10.1038/s41390-020-01328-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-020-01328-y
Further reading
-
Concentrations of oligosaccharides in human milk and child growth
BMC Pediatrics (2021)